secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-10-07T18:58:41+00:00
Accession:  0001213900-26-107541
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Tessera sets CEO Oster and CFO Rokach employment pacts; equity tied to Oct. 20 stockholder vote
--------------------------------------------------------------------------------

- CEO Michael Oster gets NIS 55,000 monthly salary (~$18,000), up to 50% cash bonus, 400,000 vested shares, 1,000,000 RSUs, and 1,000,000 options at $1.15.
- Oster performance shares: 2027 EBITDA/share above $0.05 yields 200,000 shares plus 100,000 per cent, max 500,000; 2028 threshold $0.10.
- CFO David Rokach gets NIS 35,000 monthly salary (~$11,500) and 180,000 fully vested shares; awards need stockholder approval to raise plan shares from 685,000 to 6,000,000.
- Special Meeting set for Oct. 20, 2026; Oster pact includes 12-month severance after change in control, full vesting, and option exercise extension to 12 months.
- Company says it raised over $6 million via ATM at ~$1.15 average and a financing source added $5 million line of credit; it acquired Zorronet and DFSL.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026107541/0001213900-26-107541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026107541/ea0307961-8k_tessera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-107541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer